Short Interest in PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Decreases By 81.4%

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) was the recipient of a large decline in short interest in the month of August. As of August 31st, there was short interest totaling 17,878 shares, a decline of 81.4% from the August 15th total of 95,953 shares. Based on an average daily trading volume, of 345,630 shares, the short-interest ratio is currently 0.1 days.

PharmaTher Stock Performance

OTCMKTS:PHRRF traded down $0.00 on Friday, reaching $0.04. The stock had a trading volume of 11,620 shares, compared to its average volume of 165,396. The company has a 50-day moving average of $0.04 and a 200 day moving average of $0.05. PharmaTher has a 12-month low of $0.03 and a 12-month high of $0.30.

About PharmaTher

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.